Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Insulin Resistance × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 41 Myelodysplastic Syndromes 18 Breast Neoplasms 18 Leukemia, Myelomonocytic, Chronic 12 Prostatic Neoplasms 10 Neoplasms 10 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Myeloproliferative Disorders 5 Multiple Myeloma 5 Lymphoma, B-Cell 5 Esophageal Neoplasms 5 Sarcoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Melanoma 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3 Squamous Cell Carcinoma of Head and Neck 3 Primary Myelofibrosis 3 Polycythemia Vera 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

Metformin 26 Pioglitazone 7 Exercise 7 Inositol 5 Insulin 4 Acupuncture Therapy 4 Ethinyl Estradiol 3 salicylsalicylic acid 2 drospirenone and ethinyl estradiol combination 2 Water 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Resistance Training 2 High-Intensity Interval Training 2 Folic Acid 2 Diet Therapy 2 Cyproterone Acetate 2 Caloric Restriction 2 ziprasidone 1 maltodextrin 1 lime 1 drospirenone 1 cinnulin PF 1 adrenosterone 1 World Health Organization oral rehydration solution 1 Waist-Hip Ratio 1 Waist Circumference 1 Vitamin D 1 Tirzepatide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡